UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035619
Receipt number R000040577
Scientific Title Clinical trials on efficacy and safety of 3 novel combinations of Nobiletin, Kaempferia parviflora and Peucedanum japonicum for urine storage disorder
Date of disclosure of the study information 2019/01/22
Last modified on 2022/08/08 16:00:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trials on efficacy and safety of 3 novel combinations of Nobiletin, Kaempferia parviflora and Peucedanum japonicum for urine storage disorder

Acronym

Clinical trials of Nobiletin, Kaempferia parviflora and Peucedanum japonicum for urine storage disorder

Scientific Title

Clinical trials on efficacy and safety of 3 novel combinations of Nobiletin, Kaempferia parviflora and Peucedanum japonicum for urine storage disorder

Scientific Title:Acronym

Clinical trials of Nobiletin, Kaempferia parviflora and Peucedanum japonicum for urine storage disorder

Region

Japan


Condition

Condition

Urine storage disorders (urinary frequency, nocturia, urinary urgency, urgency incontinence)

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Adult volunteers with urine storage disorder (urinary frequency, nocturia, urinary urgency, urgency incontinence) are administered with 3 combination drugs such as Nobiletin, Kaempferia parviflora and Peucedanum japonicum, and the effectiveness is examined. In succession, the effectiveness and safety of 3 volumes of three drug combinations (3 volumes 3 mixture) for urine storage disorder are examined.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

overactive bladder symptom score

Key secondary outcomes

International prostate symptom score and QOL score


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Using 600 mg of 3 capsules (600 mg of content: Nobiletin high purity (60%) Seikwasa extract, Novilex 55 mg + Kaempferia parviflora dry powder 388 mg + Peucedanum japonicum dry powder 100 mg + crystalline cellulose 30 mg / + glycerin fatty acid ester 18 mg + fine silicon dioxide 9 mg) . Administration is 3 capsules once a day for the first 3 weeks and 9 capsules once a day for the remaining 4 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

urine storage disorders (urinary frequency, nocturia, urinary urgency, urgency incontinence) have been present for more than 2 months but untreated adults

Key exclusion criteria

1.Those who are being treated for dysuria
2.Within two months of termination of treatment of voiding disorder
3.Those with no urinary trust
4.Difficulty of urination is the main symptom
5.Those with difficult communication difficulties

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kimio
Middle name
Last name Sugaya

Organization

Kitakami Central Hospital. Department of Urology

Division name

Director

Zip code

904-0101

Address

631-9 Kamisedo, Chatan, Okinawa, 904-0101, Japan

TEL

098-936-5111

Email

sugaya@medu-ryukyu.ac.jp


Public contact

Name of contact person

1st name Kimio
Middle name
Last name Sugaya

Organization

Kitakami Central Hospital. Department of Urology

Division name

Director

Zip code

904-0101

Address

631-9 Kamisedo, Chatan, Okinawa, 904-0101, Japan

TEL

098-936-5111

Homepage URL


Email

sugaya@medu-ryukyu.ac.jp


Sponsor or person

Institute

Southern Knights' Laboratory

Institute

Department

Personal name



Funding Source

Organization

Okinawa Research Center Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawahara Urological Clinic

Address

73-3 Nishimotida, Aira, Kagoshima, Japan

Tel

0995-64-5181

Email

yamashita.hami@kawahara.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北上中央病院(沖縄県)


Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 22 Day


Related information

URL releasing protocol

Shinryo to Shinyaku, 2020; 57: 923-929

Publication of results

Published


Result

URL related to results and publications

Shinryo to Shinyaku, 2020; 57: 923-929

Number of participants that the trial has enrolled

20

Results

Shinryo to Shinyaku, 2020; 57: 923-929

Results date posted

2022 Year 08 Month 08 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Shinryo to Shinyaku, 2020; 57: 923-929

Participant flow

Shinryo to Shinyaku, 2020; 57: 923-929

Adverse events

Shinryo to Shinyaku, 2020; 57: 923-929

Outcome measures

Shinryo to Shinyaku, 2020; 57: 923-929

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 12 Month 21 Day

Date of IRB

2019 Year 01 Month 12 Day

Anticipated trial start date

2019 Year 01 Month 28 Day

Last follow-up date

2019 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 22 Day

Last modified on

2022 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040577


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name